Latest filings (excl ownership)
425
Business combination disclosure
24 Jan 24
8-K
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
24 Jan 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
25 Aug 23
8-K
Bowen Acquisition Corp
15 Aug 23
8-K
Bowen Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
14 Aug 23
8-K
Bowen Acquisition Corp
20 Jul 23
8-K
Bowen Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
14 Jul 23
EFFECT
Notice of effectiveness
12 Jul 23
424B4
Prospectus supplement with pricing info
12 Jul 23
CERT
Certification of approval for exchange listing
11 Jul 23
8-A12B
Registration of securities on exchange
10 Jul 23
CORRESP
Correspondence with SEC
6 Jul 23
CORRESP
Correspondence with SEC
6 Jul 23
S-1/A
IPO registration (amended)
13 Jun 23
S-1
IPO registration
19 May 23
CORRESP
Correspondence with SEC
19 May 23
UPLOAD
Letter from SEC
10 May 23
DRS
Draft registration statement
17 Apr 23
Latest ownership filings
SC 13D
Createcharm Holdings Ltd
15 Feb 24
SC 13D
Bowen Holding LP
15 Feb 24
SC 13G
PERISCOPE CAPITAL INC.
9 Feb 24
SC 13G
Bulldog Investors, LLP
1 Feb 24
SC 13G/A
Harraden Circle Investments, LLC
31 Jan 24
SC 13G
SPRING CREEK CAPITAL LLC
19 Sep 23
SC 13G
Harraden Circle Investments, LLC
18 Jul 23
3
Jun Zhang
11 Jul 23
3
Wei Li
11 Jul 23
3
Lawrence W. Leighton
11 Jul 23
3
Jing Lu
11 Jul 23
3
Jiangang Luo
11 Jul 23
3
Initial statement of insider ownership
11 Jul 23
3
Na Gai
11 Jul 23